Although no typical CCR diauxie growth was observed, we detected slower utilization of L-arabinose than D-glucose or D-xylose by C. cellulolyticum H10 in batch fermentation.
As previously observed, we detected radiolabeled bands in the Δmto1 strain corresponding to ribosomal protein Var1, cytochrome c oxidase subunit 3 (Cox3), and Atp subunits (Atp6, Atp8, Atp9), whose levels were similar to those of the MTO1 strain.
In addition, although peripheral blood cytopenia was observed, we also detected dysplasia of blood cell development during hematopoiesis.
Interestingly, and as previously observed, we also detected significant downregulation of various cytokines and chemokines: interleukin enhancer binding factor 2 (interleukinrleukin 13 receptor alpha 1 (Ileukemia leukeminhibitoryory factor (LIF), cardiotrophin-like cytokine (CLC), chemokine C C ligand 2 (CCL2), and chemokine C X C ligand 1 (CXCL1).
In the case of BCL9-2, each mutant was inactive (i.e. no synergy with Wnt stimulation was observed), and we detected slight albeit statistically significant DN effects of ΔHD1 and L411K ΔHD1 for one target gene each (Fig. 3C).
As observed for SERPINE1, we detected a slight decrease in VEGFA expression in lymphatic tissues in the preclinical stage of natural scrapie, followed by a moderate increase during the clinical stage of the disease.
As previously observed (Rocha 2002), we detected a strong trend for non-IS genes to be placed in the leading strand (i.e., direction of movement of the replication fork) in Firmicutes and Tenericutes but not in other groups (fig. 2 A).
The analysis of the aa changes that occurred on the V3 region (Fig. 5Bii, lower panel) indicated that a great number of changes were observed in this region (in agreement to be a highly variable region) explaining the high subtype specificity observed (we could only detect the specific responses with the clade-matched peptide, (i.e.: IIIB with IIIB, but not with the consensus B peptide).
At later stages of development when larger increases in Tbr2+ cells and Tuj1+ cells were observed we did detect significant declines in the numbers of Pax6+ cells.
Even in the case of AZD-6244 treatment, where a very low and no significant effect on cell proliferation was observed, we could detect a small increase in the subG1 cell population without any sign of cell accumulation in G1, as opposed to the results obtained in HT-29 cells.
While no major developmental abnormalities were observed, after recurrent seizures we detected neuronal loss, mossy fibre sprouting, astrocyte reactivity and granule cell dispersion in the hippocampus of LGI1−/− mice.
